
Side by side
Compare compounds
Add up to three compounds with the compare button on any library card or compound page.
Swipe the table sideways to see every compound.
| Attribute | ![]() |
|---|---|
| Category | Metabolic |
| Evidence grade | A Human trial evidence |
| Regulatory status | FDA-approved |
| Human amounts | FDA labelDosing reference Study durations |
| Format | |
| Type | Single compound |
| Molecular formula | Not listed |
| Molecular weight | 63,000 g/mol |
| CAS number | Not listed |
| Sequence | Not listed |
| References | 6 |
| Summary | Dulaglutide is a once-weekly GLP-1 receptor agonist fusion protein, FDA-approved as Trulicity for glycemic control in type 2 diabetes (adults and children 10 years and older) and for reducing major adverse cardiovascular events in adults with type 2 diabetes. |
